Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications - PubMed (original) (raw)
. 2019 Oct 15;125(20):3554-3565.
doi: 10.1002/cncr.32369. Epub 2019 Jul 16.
Affiliations
- PMID: 31310330
- DOI: 10.1002/cncr.32369
Free article
Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications
Clarence T Sasaki et al. Cancer. 2019.
Free article
Abstract
Background: Recent preclinical explorations strongly support the tumorigenic potential of bile on laryngopharyngeal mucosa. Herein, the authors describe, in bile-related human hypopharyngeal squamous cell carcinoma (HSCC), NF-κB-related messenger RNA (mRNA) and microRNA (miRNA) oncogenic phenotypes similar to those previously identified in acidic bile-exposed premalignant murine hypopharyngeal mucosa.
Methods: In this pilot study, the authors included human HSCC specimens paired with their adjacent normal tissue (ANT) derived from 3 representative patients with documented biliary laryngopharyngeal reflux (bile[+]) compared with 5 control patients without signs of bile reflux disease (bile[-]). Immunohistochemical, quantitative polymerase chain reaction, and miRNA analyses were used to detect the levels of activated NF-κB and expression levels of STAT3, EGFR, BCL2, WNT5A, IL-6, IL-1B, ΔNp63, cREL, TNF-α, TP53, NOTCH1, NOTCH2, NOTCH3, miR-21, miR-155, miR-192, miR-34a, miR-375, miR-451a, miR-489, miR-504, and miR-99a.
Results: Bile(+) HSCC demonstrated an intense NF-κB activation accompanied by significant overexpression of RELA(p65), EGFR, STAT3, BCL-2, cREL, ΔNp63, WNT5A, IL-6, and IL1B; upregulation of oncomir miR-21; and downregulation of tumor suppressor miR-375 compared with their respective ANTs. Bile(+) HSCC demonstrated significantly higher mRNA levels of all the analyzed genes, particularly RELA(p65), IL-6, EGFR, and TNF-α compared with bile(-) tumors. The miR-21/miR-375 ratio, which previously has been linked to tumor aggressiveness, was found to be >260-fold and >30-fold higher, respectively, in bile(+) HSCCs compared with their ANTs and bile(-) tumors.
Conclusions: Although limitations apply to this pilot study due to the small number of patients with HSCC, the novel findings suggest that a history of bile as a component of esophageal reflux disease may represent an independent risk factor for hypopharyngeal carcinogenesis.
Keywords: NF-κB; bile reflux; hypopharyngeal cancer; miR-21; miR-375.
© 2019 American Cancer Society.
Similar articles
- Pepsin and Laryngeal and Hypopharyngeal Carcinomas.
Yin CY, Zhang SS, Zhong JT, Zhou SH. Yin CY, et al. Clin Exp Otorhinolaryngol. 2021 May;14(2):159-168. doi: 10.21053/ceo.2020.00465. Epub 2020 Jul 24. Clin Exp Otorhinolaryngol. 2021. PMID: 32734742 Free PMC article. Review. - Bile reflux and hypopharyngeal cancer (Review).
Vageli DP, Doukas SG, Doukas PG, Judson BL. Vageli DP, et al. Oncol Rep. 2021 Nov;46(5):244. doi: 10.3892/or.2021.8195. Epub 2021 Sep 24. Oncol Rep. 2021. PMID: 34558652 Free PMC article. Review. - The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer.
Sasaki CT, Hajek M, Doukas SG, Vageli DP. Sasaki CT, et al. Oral Oncol. 2020 Jun;105:104668. doi: 10.1016/j.oraloncology.2020.104668. Epub 2020 Apr 2. Oral Oncol. 2020. PMID: 32247988 - In Vivo Short-Term Topical Application of BAY 11-7082 Prevents the Acidic Bile-Induced mRNA and miRNA Oncogenic Phenotypes in Exposed Murine Hypopharyngeal Mucosa.
Sasaki CT, Doukas SG, Vageli DP. Sasaki CT, et al. Neoplasia. 2018 Apr;20(4):374-386. doi: 10.1016/j.neo.2018.02.001. Epub 2018 Mar 9. Neoplasia. 2018. PMID: 29529473 Free PMC article. - Curcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells.
Vageli DP, Doukas SG, Spock T, Sasaki CT. Vageli DP, et al. J Cell Mol Med. 2018 Sep;22(9):4209-4220. doi: 10.1111/jcmm.13701. Epub 2018 Jun 17. J Cell Mol Med. 2018. PMID: 29911313 Free PMC article.
Cited by
- Pepsin and Laryngeal and Hypopharyngeal Carcinomas.
Yin CY, Zhang SS, Zhong JT, Zhou SH. Yin CY, et al. Clin Exp Otorhinolaryngol. 2021 May;14(2):159-168. doi: 10.21053/ceo.2020.00465. Epub 2020 Jul 24. Clin Exp Otorhinolaryngol. 2021. PMID: 32734742 Free PMC article. Review. - Laryngopharyngeal Reflux Pathophysiology, Clinical Presentation, and Management: A Narrative Review.
Barham WT, Alvarez-Amado AV, Dillman KM, Thibodeaux E, Nguyen ID, Varrassi G, Armstrong CJ, Howard J, Ahmadzadeh S, Mosieri CN, Kaye AM, Shekoohi S, Kaye AD. Barham WT, et al. Cureus. 2024 Aug 20;16(8):e67305. doi: 10.7759/cureus.67305. eCollection 2024 Aug. Cureus. 2024. PMID: 39301397 Free PMC article. Review. - Bile reflux and hypopharyngeal cancer (Review).
Vageli DP, Doukas SG, Doukas PG, Judson BL. Vageli DP, et al. Oncol Rep. 2021 Nov;46(5):244. doi: 10.3892/or.2021.8195. Epub 2021 Sep 24. Oncol Rep. 2021. PMID: 34558652 Free PMC article. Review. - The in vivo preventive and therapeutic properties of curcumin in bile reflux-related oncogenesis of the hypopharynx.
Doukas SG, Doukas PG, Sasaki CT, Vageli D. Doukas SG, et al. J Cell Mol Med. 2020 Sep;24(18):10311-10321. doi: 10.1111/jcmm.15640. Epub 2020 Jul 21. J Cell Mol Med. 2020. PMID: 32691972 Free PMC article. - The Effect of Tobacco Smoke _N_-Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence.
Doukas SG, Vageli DP, Doukas PG, Nikitovic D, Tsatsakis A, Judson BL. Doukas SG, et al. Curr Oncol. 2022 Aug 4;29(8):5531-5549. doi: 10.3390/curroncol29080437. Curr Oncol. 2022. PMID: 36005175 Free PMC article.
References
- Hashibe M, Boffetta P, Zaridze D, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol. 2007;165:814-820.
- Parsel SM, Wu EL, Riley CA, McCoul ED. Gastroesophageal and laryngopharyngeal reflux associated with laryngeal malignancy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1253-1264.e5.
- Galli J, Cammarota G, De Corso E, et al. Biliary laryngopharyngeal reflux: a new pathological entity. Curr Opin Otolaryngol Head Neck Surg. 2006;14:128-132.
- Farhana L, Nangia-Makker P, Arbit E, et al. Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Res Ther. 2016;7:181.
- Matsuzaki J, Suzuki H. Bile acids and esophageal cancer. In: Tazuma S, Takikawa H, eds. Bile Acids in Gastroenterology. Tokyo: Springer; 2017:177-184.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous